Back to results
US 2006/0067913 A1Published application
HCV therapy
OwnerRupert Holms, Ravshan Ataullakhanovinventors
Life of this patent
Estimating the term…
Abstract
A peptide which has at least 80% identity to a fragment of Domain A or B of the Hepreceptor of ezrin, is used in the treatment of viral hepatitis.
Claims5
A method for the treatment of a patient who has viral hepatitis, which comprises administering to the patient a therapeutically effective amount of a peptide that comprises a sequence having at least 80% identity to a fragment of Domain A or B of the Hepreceptor of ezrin, and wherein the peptide binds to the Hepreceptor with at least as great affinity as TEKKRRETVEREKE HEP1.
Dependencies are inferred from the claim text.